Suppr超能文献

基于纵向生物标志物的预测分类

Prediction based classification for longitudinal biomarkers.

作者信息

Foulkes A S, Azzoni L, Li X, Johnson M A, Smith C, Mounzer K, Montaner L J

机构信息

Division of Biostatistics, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA USA.

出版信息

Ann Appl Stat. 2010 Sep;4(3):1476-1497. doi: 10.1214/10-AOAS326.

Abstract

Assessment of circulating CD4 count change over time in HIV-infected subjects on antiretroviral therapy (ART) is a central component of disease monitoring. The increasing number of HIV-infected subjects starting therapy and the limited capacity to support CD4 count testing within resource-limited settings have fueled interest in identifying correlates of CD4 count change such as total lymphocyte count, among others. The application of modeling techniques will be essential to this endeavor due to the typically non-linear CD4 trajectory over time and the multiple input variables necessary for capturing CD4 variability. We propose a prediction based classification approach that involves first stage modeling and subsequent classification based on clinically meaningful thresholds. This approach draws on existing analytical methods described in the receiver operating characteristic curve literature while presenting an extension for handling a continuous outcome. Application of this method to an independent test sample results in greater than 98% positive predictive value for CD4 count change. The prediction algorithm is derived based on a cohort of n = 270 HIV-1 infected individuals from the Royal Free Hospital, London who were followed for up to three years from initiation of ART. A test sample comprised of n = 72 individuals from Philadelphia and followed for a similar length of time is used for validation. Results suggest that this approach may be a useful tool for prioritizing limited laboratory resources for CD4 testing after subjects start antiretroviral therapy.

摘要

评估接受抗逆转录病毒疗法(ART)的HIV感染受试者随时间推移循环CD4细胞计数的变化是疾病监测的核心组成部分。开始接受治疗的HIV感染受试者数量不断增加,而资源有限环境下支持CD4细胞计数检测的能力有限,这激发了人们对确定CD4细胞计数变化相关因素(如总淋巴细胞计数等)的兴趣。由于CD4细胞计数随时间的变化轨迹通常是非线性的,且捕获CD4细胞计数变异性需要多个输入变量,因此建模技术的应用对于这项工作至关重要。我们提出了一种基于预测的分类方法,该方法包括第一阶段建模以及随后基于临床有意义阈值的分类。这种方法借鉴了接受者操作特征曲线文献中描述的现有分析方法,同时提出了一种处理连续结果的扩展方法。将该方法应用于独立测试样本时,CD4细胞计数变化的阳性预测值大于98%。该预测算法是基于伦敦皇家自由医院的270名HIV-1感染个体组成的队列推导出来的,这些个体从开始接受ART起被随访了长达三年。一个由来自费城的72名个体组成的测试样本,随访时间相似,用于验证。结果表明,这种方法可能是一种有用的工具,可用于在受试者开始抗逆转录病毒治疗后,为CD4检测优先分配有限的实验室资源。

相似文献

1
Prediction based classification for longitudinal biomarkers.
Ann Appl Stat. 2010 Sep;4(3):1476-1497. doi: 10.1214/10-AOAS326.
6
Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.
J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):712. doi: 10.1007/s11596-011-0588-8. Epub 2011 Oct 25.
8
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Cochrane Database Syst Rev. 2014 May 22;2014(5):CD004772. doi: 10.1002/14651858.CD004772.pub4.
10
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
BMC Infect Dis. 2012 Jun 7;12:128. doi: 10.1186/1471-2334-12-128.

引用本文的文献

1
2
Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression.
Stat Med. 2020 Mar 15;39(6):740-756. doi: 10.1002/sim.8443. Epub 2019 Dec 9.
3
Use of paediatric early warning scores in intermediate care units.
Arch Dis Child. 2020 Feb;105(2):173-179. doi: 10.1136/archdischild-2019-317055. Epub 2019 Aug 10.
4
The ROC curve for regularly measured longitudinal biomarkers.
Biostatistics. 2019 Jul 1;20(3):433-451. doi: 10.1093/biostatistics/kxy010.
8
A linear mixed model for predicting a binary event from longitudinal data under random effects misspecification.
Stat Med. 2012 Jan 30;31(2):143-54. doi: 10.1002/sim.4405. Epub 2011 Nov 14.

本文引用的文献

5
Evaluating technologies for classification and prediction in medicine.
Stat Med. 2005 Dec 30;24(24):3687-96. doi: 10.1002/sim.2431.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验